https://investor.ironwoodpharma.com/press-releases/press-release-details/2016/Ironwood-and-Allergan-Announce-Supplemental-New-Drug-Application-for-72-mcg-Linaclotide-in-Chronic-Idiopathic-Constipation-Has-Been-Accepted-for-FDA-Review/default.aspx
Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.
- June 9, 2016